These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38592304)

  • 21. The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer's Disease.
    Zhong L; Chen XF
    Front Aging Neurosci; 2019; 11():328. PubMed ID: 32038221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease.
    Ozaki Y; Yoshino Y; Yamazaki K; Sao T; Mori Y; Ochi S; Yoshida T; Mori T; Iga JI; Ueno SI
    J Psychiatr Res; 2017 Sep; 92():74-80. PubMed ID: 28412600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway.
    Ruganzu JB; Zheng Q; Wu X; He Y; Peng X; Jin H; Zhou J; Ma R; Ji S; Ma Y; Qian Y; Wang Y; Yang W
    Exp Neurol; 2021 Feb; 336():113506. PubMed ID: 33065077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral TREM2 mRNA levels in early and late-onset Alzheimer disease's patients.
    Guven G; Bilgic B; Samanci B; Gurvit H; Hanagasi H; Donmez C; Aslan R; Lohmann E; Erginel-Unaltuna N
    Mol Biol Rep; 2020 Aug; 47(8):5903-5909. PubMed ID: 32681391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treadmill exercise improve recognition memory by TREM2 pathway to inhibit hippocampal microglial activation and neuroinflammation in Alzheimer's disease model.
    Zhang L; Liu Y; Wang X; Wang D; Wu H; Chen H; Chen J; Liu Y
    Physiol Behav; 2022 Jul; 251():113820. PubMed ID: 35452628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer's Disease.
    La Rosa F; Agostini S; Piancone F; Marventano I; Hernis A; Fenoglio C; Galimberti D; Scarpini E; Saresella M; Clerici M
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.
    Raha-Chowdhury R; Henderson JW; Raha AA; Stott SRW; Vuono R; Foscarin S; Wilson L; Annus T; Fincham R; Allinson K; Devalia V; Friedland RP; Holland A; Zaman SH
    J Alzheimers Dis; 2018; 61(3):1143-1162. PubMed ID: 29278889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice.
    Jiang T; Yu JT; Zhu XC; Tan MS; Gu LZ; Zhang YD; Tan L
    Neurobiol Aging; 2014 Jun; 35(6):1243-51. PubMed ID: 24368090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease.
    Li Y; Xu H; Wang H; Yang K; Luan J; Wang S
    Biomed Pharmacother; 2023 Sep; 165():115218. PubMed ID: 37517293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice.
    Qu W; Li L
    J Neurosci; 2020 Dec; 40(50):9552-9563. PubMed ID: 33139402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K/AKT/FoxO3a signaling pathway in Alzheimer's disease mice.
    Wang Y; Lin Y; Wang L; Zhan H; Luo X; Zeng Y; Wu W; Zhang X; Wang F
    Aging (Albany NY); 2020 Oct; 12(20):20862-20879. PubMed ID: 33065553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
    Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
    Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
    Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
    Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of TREM2 attenuates neuroinflammation via PI3K/Akt signaling pathway to improve postoperative cognitive dysfunction in mice.
    Han X; Cheng X; Xu J; Liu Y; Zhou J; Jiang L; Gu X; Xia T
    Neuropharmacology; 2022 Nov; 219():109231. PubMed ID: 36041498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment.
    Qiu S; Palavicini JP; Wang J; Gonzalez NS; He S; Dustin E; Zou C; Ding L; Bhattacharjee A; Van Skike CE; Galvan V; Dupree JL; Han X
    Mol Neurodegener; 2021 Sep; 16(1):64. PubMed ID: 34526055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease.
    Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT
    Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias.
    Shafi S; Singh A; Ibrahim AM; Alhajri N; Abu Izneid T; Pottoo FH
    Eur J Neurosci; 2021 May; 53(10):3294-3310. PubMed ID: 33786894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.
    Henjum K; Almdahl IS; Årskog V; Minthon L; Hansson O; Fladby T; Nilsson LN
    Alzheimers Res Ther; 2016 Apr; 8(1):17. PubMed ID: 27121148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
    Xiang X; Piers TM; Wefers B; Zhu K; Mallach A; Brunner B; Kleinberger G; Song W; Colonna M; Herms J; Wurst W; Pocock JM; Haass C
    Mol Neurodegener; 2018 Sep; 13(1):49. PubMed ID: 30185230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPARγ.
    Strobel S; Grünblatt E; Riederer P; Heinsen H; Arzberger T; Al-Sarraj S; Troakes C; Ferrer I; Monoranu CM
    J Neural Transm (Vienna); 2015 Jul; 122(7):1069-76. PubMed ID: 25596843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.